SEVENTH AMENDMENT TO LICENSE AGREEMENT FOR INTERFERON GAMMALicense Agreement • February 27th, 2015 • Horizon Pharma PLC • Pharmaceutical preparations
Contract Type FiledFebruary 27th, 2015 Company IndustryThis Seventh Amendment To License Agreement for Interferon Gamma (hereinafter “Seventh Amendment”) is entered into effective December 17, 2013 (the “Seventh Amendment Effective Date”) by and between Genentech, Inc, (“Genentech”) and Vidara Therapeutics International Limited, (“Vidara”), who are now Parties to the License Agreement for Interferon Gamma dated May 5, 1998, as amended. Genentech and Vidara may each be referred to herein as a “Party” and jointly as the “Parties.”
SEVENTH AMENDMENT TO LICENSE AGREEMENT FOR INTERFERON GAMMALicense Agreement • June 26th, 2014 • Vidara Therapeutics International LTD
Contract Type FiledJune 26th, 2014 CompanyThis Seventh Amendment To License Agreement for Interferon Gamma (hereinafter “Seventh Amendment”) is entered into effective December 17, 2013 (the “Seventh Amendment Effective Date”) by and between Genentech, Inc, (“Genentech”) and Vidara Therapeutics International Limited, (“Vidara”), who are now Parties to the License Agreement for Interferon Gamma dated May 5, 1998, as amended. Genentech and Vidara may each be referred to herein as a “Party” and jointly as the “Parties.”